Recent Advances in the Management of Gastrointestinal Cancer: Focus on Precision Medicine
Last Modified: August 21, 2013
Dates: December 13, 2013
Location: The Hub Cira Center, 2929 Arch Street, Mezzanine Level, Philadelphia, PA
Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania and Perelman School of Medicine at the University of Pennsylvania
Rare tumors of the GI tract and personalized therapy
At the completion of this course, participants should be able to:
- Summarize the latest information in the management of neuroendocrine tumors
- Understand adjuvant and neoadjuvant treatment options for gastrointestinal cancers
- Identify prognostic markers for future diagnostic and treatment options for gastrointestinal cancers
- Discuss genomic testing for personalized therapies that alters patients' treatment and prognosis
- Assess the current status of translational research in cancer genetics for treatment and prevention
- Identify targeted interventions, such as protons and personalized therapy for the treatment of gastrointestinal cancers
Who Should Attend
This course is designed for primary care physicians, gstroenterologists, surgical, medical, and radiation oncologists, endocrinologists, interventional diagnostic radiologists, pathologists, hematology/oncology fellows, oncology nurses, and other healthcare professionals involved in the treatment of patients with gastrointestinal cancers.
Registration Information: To request a brochure, please contact Mary M. Graham at firstname.lastname@example.org Registration will begin in October.
Fees: $50 physicians, $25 nurses and other healthcare providers
Continuing Education: Yes
Miscellany: This course has been approved for CME and CE credits.